VERTEX PHARMACEUTICALS INC

Ticker: VRTX CUSIP: 92532F100 Class: EQTY

Cravens & Co Advisors, LLC's Holding History (CIK: 0001966116)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 2,797 Value ($000) $1,272 Avg Close $431.03 Range $392.50 - $464.44

Q3 2025

Shares 3,277 Value ($000) $1,283 Avg Close $417.92 Range $362.50 - $484.56

Q2 2025

Shares 2,241 Value ($000) $998 Avg Close $460.83 Range $416.60 - $510.77

Q1 2025

Shares 2,178 Value ($000) $1,056 Avg Close $466.00 Range $397.25 - $519.68

Q4 2024

Shares 2,162 Value ($000) $871 Avg Close $463.53 Range $377.85 - $519.88

Q3 2024

Shares 2,208 Value ($000) $1,027 Avg Close $480.37 Range $456.07 - $510.64

Q2 2024

Shares 2,276 Value ($000) $1,067 Avg Close $434.05 Range $391.01 - $486.43

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	2,797	$1,272	$431.03	$392.50 - $464.44
Q3 2025	3,277	$1,283	$417.92	$362.50 - $484.56
Q2 2025	2,241	$998	$460.83	$416.60 - $510.77
Q1 2025	2,178	$1,056	$466.00	$397.25 - $519.68
Q4 2024	2,162	$871	$463.53	$377.85 - $519.88
Q3 2024	2,208	$1,027	$480.37	$456.07 - $510.64
Q2 2024	2,276	$1,067	$434.05	$391.01 - $486.43